North American Cannabis Holdings, Inc.
USMJ · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | 0.01 | 0.00 | -0.01 |
| FCF Yield | -647.19% | 7.74% | 67.96% | -1.97% |
| EV / EBITDA | -846.09 | -677.81 | -181.23 | 734.59 |
| Quality | ||||
| ROIC | 0.50% | 0.60% | 2.25% | -0.57% |
| Gross Margin | 0.00% | 73.39% | 67.83% | 68.49% |
| Cash Conversion Ratio | 40.85 | -0.41 | -0.01 | -0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 505,850.24% | 575,510.94% | 624,481.05% | 618,833.30% |
| Free Cash Flow Growth | -8,460.91% | -92.41% | 4,366.67% | -100.50% |
| Safety | ||||
| Net Debt / EBITDA | -839.77 | -672.49 | -179.10 | 727.65 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.36 | 0.38 |
| Cash Conversion Cycle | 0.00 | -65,035.08 | -403.26 | -289.67 |